Hoth Historical Financial Ratios
| HOTH Stock | USD 0.83 0.01 1.22% |
Hoth Therapeutics is recently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.53 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Hoth Therapeutics financial condition quickly.
Hoth |
About Hoth Financial Ratios Analysis
Hoth TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Hoth Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Hoth financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Hoth Therapeutics history.
Hoth Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Hoth Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Hoth Therapeutics sales, a figure that is much harder to manipulate than other Hoth Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Hoth Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' EV To Free Cash Flow is increasing as compared to previous years. The Hoth Therapeutics' current Net Debt To EBITDA is estimated to increase to 57.00, while PTB Ratio is projected to decrease to 0.53.
| 2023 | 2024 (projected) | PB Ratio | 0.56 | 0.53 | Capex To Depreciation | 184.64 | 175.4 |
Hoth Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Book Value Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.27 | |
| Free Cash Flow Yield | (0.0889) | (0.22) | (0.83) | (1.0) | (1.72) | (1.63) | |
| Operating Cash Flow Per Share | (13.5) | (12.4) | (13.54) | (7.76) | (2.48) | (2.6) | |
| Pb Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Free Cash Flow Per Share | (13.75) | (12.74) | (13.67) | (7.83) | (2.48) | (2.6) | |
| Roic | (3.22) | (1.53) | (1.43) | (2.22) | (0.87) | (0.91) | |
| Net Income Per Share | (20.99) | (14.56) | (16.03) | (9.75) | (2.3) | (2.42) | |
| Cash Per Share | 6.8 | 9.49 | 11.68 | 5.54 | 2.73 | 4.59 | |
| Pocfratio | (11.47) | (4.78) | (1.22) | (1.0) | (0.58) | (0.61) | |
| Pfcf Ratio | (11.25) | (4.65) | (1.21) | (1.0) | (0.58) | (0.61) | |
| Days Payables Outstanding | 4.7K | 1.8K | 2.81 | 3.8K | 4.4K | 4.1K | |
| Income Quality | 0.84 | 0.64 | 0.85 | 0.82 | 1.08 | 0.61 | |
| Roe | (3.21) | (1.55) | (1.45) | (2.28) | (0.89) | (0.93) | |
| Ev To Operating Cash Flow | (11.13) | (4.35) | (0.51) | (0.31) | 0.51 | 0.54 | |
| Pe Ratio | (7.37) | (4.07) | (1.03) | (0.8) | (0.63) | (0.66) | |
| Return On Tangible Assets | (2.71) | (1.37) | (1.3) | (1.73) | (0.82) | (0.87) | |
| Ev To Free Cash Flow | (10.92) | (4.23) | (0.51) | (0.31) | 0.51 | 0.54 | |
| Earnings Yield | (0.14) | (0.25) | (0.97) | (1.25) | (1.6) | (1.52) | |
| Net Debt To E B I T D A | 0.11 | 0.22 | 0.36 | 60.32 | 54.28 | 57.0 | |
| Current Ratio | 5.99 | 15.32 | 12.19 | 4.85 | 13.89 | 12.34 | |
| Tangible Book Value Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.27 | |
| Graham Number | 55.56 | 55.47 | 63.16 | 30.63 | 11.57 | 10.99 | |
| Shareholders Equity Per Share | 6.54 | 9.39 | 11.06 | 4.28 | 2.59 | 4.27 | |
| Graham Net Net | 5.6 | 8.28 | (42.07) | 4.18 | 2.52 | 2.64 | |
| Enterprise Value Over E B I T D A | (7.14) | (3.65) | (0.44) | 28.26 | 25.43 | 26.71 | |
| Price Earnings Ratio | (7.37) | (4.07) | (1.03) | (0.8) | (0.63) | (0.66) | |
| Price Book Value Ratio | 23.68 | 6.31 | 1.49 | 1.82 | 0.56 | 0.53 | |
| Price Earnings To Growth Ratio | (0.034) | 0.13 | (0.1) | 0.0204 | 0.008189 | 0.008599 | |
| Days Of Payables Outstanding | 4.7K | 1.8K | 2.81 | 3.8K | 4.4K | 4.1K | |
| Price To Operating Cash Flows Ratio | (11.47) | (4.78) | (1.22) | (1.0) | (0.58) | (0.61) | |
| Price To Free Cash Flows Ratio | (11.25) | (4.65) | (1.21) | (1.0) | (0.58) | (0.61) | |
| Effective Tax Rate | 0.001345 | 0.0285 | 0.0 | (0.0269) | (0.0309) | (0.0293) | |
| Company Equity Multiplier | 1.18 | 1.13 | 1.11 | 1.32 | 1.08 | 1.6 |
Currently Active Assets on Macroaxis
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.46) | Return On Equity (0.83) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.